Diamyd (GAD65) is published in the New England Journal of Medicine.
It's the 30 month followup phase II results on Juvenile Type 1 Diabetes which was very successful and is in our minds the most promising treatment towards a cure for newly diagnosed and LADA patients.
Diamyd is currently recruiting in Europe and USA for two Phase III trials.
Link to article (GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes).
Another article mentioning Diamyd (GAD65) Immunotherapy on Trial for New-Onset Type 1 Diabetes.
Wednesday, October 8, 2008
Diamyd published in New England Journal of Medicine
Subscribe to:
Post Comments (Atom)
Posts
1 comments:
order viagra online viagra 100mg buy viagra australian buy viagra cheap cheapest viagra in uk buy viagra soft online buy viagra on line effects of viagra uk viagra sales Buy Viagra Online No Prescription buy viagra in canada cheap viagra overnight viagra uk cheap purchase buy free sample prescription for viagra
Post a Comment